CODA BIOTHERAPEUTICS
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity. With chemogenetics, target neuronal populations are modified using gene therapy to express a tunable ligand-gated ion channel. These ligand-gated ion channels are engineered to be highly responsive to a specific proprietary small molecule but are otherwise inactive. The interaction of the small molecule and engineered receptor allows for exquisite, dose-dependent control of the neurons to generate the therapeutic effect.
CODA BIOTHERAPEUTICS
Social Links:
Industry:
Biotechnology Genetics Medical Therapeutics
Founded:
2014-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.codabiotherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
62.67 M USD
Technology used in webpage:
Viewport Meta Google Font API Content Delivery Network Euro Typekit LocalBusiness Schema Squarespace Comcast
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2020-02-05 | Attenua | Attenua acquired by CODA Biotherapeutics | N/A |
Investors List
Pacira Pharmaceuticals
Pacira Pharmaceuticals investment in Venture Round - CODA Biotherapeutics
MPM Capital
MPM Capital investment in Venture Round - CODA Biotherapeutics
Versant Ventures
Versant Ventures investment in Venture Round - CODA Biotherapeutics
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - CODA Biotherapeutics
National Institutes of Health
National Institutes of Health investment in Grant - CODA Biotherapeutics
Small Business Innovation Research
Small Business Innovation Research investment in Grant - CODA Biotherapeutics
Astellas Venture Management
Astellas Venture Management investment in Series A - CODA Biotherapeutics
Versant Ventures
Versant Ventures investment in Series A - CODA Biotherapeutics
MPM Capital
MPM Capital investment in Series A - CODA Biotherapeutics
MPM Capital
MPM Capital investment in Series A - CODA Biotherapeutics
Official Site Inspections
http://www.codabiotherapeutics.com
- Host name: 172.67.139.188
- IP address: 172.67.139.188
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago